Vinpocetine is a semi-synthetic derivative of vincamine, an alkaloid derived from Vinca minor L. that has been used since the 1970s in Japan, Europe, Mexico and Russia for the treatment of cognitive and cerebrovascular disorders.
Vinpocetine may also be derived from tabersonine, an alkaloid extracted from the seeds of African Voacanga.
Covex S.A. is a global manufacturer and supplier of Vinpocetine, our facilities located in Europe (Spain), make our Vinpocetine meet the highest standards. Using a proprietary patent (ES 549.105) to obtain vinpocetine through tabersonine, an alkaloid extracted from the African Voacanga.
Vincamine (VC) is also an alkaloid of the eburnamenine type.
– CAS NO: 1617-90-9
– EC NO: 216-576-3
– Molecular formula: C21H26N2O3
Identification and chemical analysis
– Generic Name (C.D.N.): Vinpocetine
– Chemical name: Eburnamenine (3α,16α)-14- carboxylic acid ethyl ester. Ethyl apovincaminate
– CAS RN: 42971-09-5
Similar standards for the identity and quality of vinpocetine products have been specified by the United States, Great Britain and European pharmacopoeias.